SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stayhealthy.com: Monitoring your wellness on the Web -- Ignore unavailable to you. Want to Upgrade?


To: Jon Matz who wrote (829)8/17/2000 9:49:18 AM
From: CrackerJack48  Respond to of 3785
 
SRGL Gets FDA Approval

Full profile available at smallcapreview.com

SurgiLight Receives FDA Clearance for the EX-308 Excimer Laser for the Treatment of Psoriasis

ORLANDO, Fla.--(BUSINESS WIRE)--Aug. 15, 2000--SurgiLight Inc., (OTCBB:SRGL - news) today announced that it has received U.S. Food and Drug Administration clearance to market the EX-308 excimer laser for the treatment of psoriasis. The EX-308 is only the second excimer laser to receive FDA clearance in the U.S. for the phototherapy treatment of psoriasis.

A summary of the clinical results for the EX-308 were recently reported at the American Academy of Dermatology in Nashville, TN, by James Spencer, M.D., Director, Dermatologic Surgery, Mount Sinai, New York, New York. ``Research indicates that the excimer laser may shorten the number of exposures necessary to clear limited areas of psoriasis,'' stated Dr. Spencer. ``Not only is this a great convenience to the patient, it also reduces their total exposure to ultraviolet radiation which causes skin cancer. In addition, only specific areas of the body are treated with the laser, again reducing the harmful side effects of ultraviolet radiation,'' he continued.

Although the cause of psoriasis is not completely understood, it is the second most common skin disorder in the United States. The National Psoriasis Foundation (NPS) estimates that psoriasis affects more than 6 million Americans and between 150,000 and 260,000 new cases are diagnosed each year. There are numerous other ways to treat psoriasis, however, the clinical results vary widely and they tend to be lengthy and too often the patient is dissatisfied with the results. Phototherapy treatment using the EX-308 to date has provided promising results and the phototherapy treatment routine appears to have dramatically reduced the number of sessions and the exposure to ultraviolet light.

J. T. Lin, Ph.D., President and CEO, commented: ``this is our first FDA clearance and we are proud of our staff and the clinicians that worked so hard on this project and look forward to treating patients that suffer from this skin disorder. The results we have received thus far have been very encouraging and we intend to continue our research to further enhance the clinical results of the EX-308 and we are looking to expand the scope of our technology to include more applications. We intend to begin marketing the EX-308 throughout the U.S. soon and worldwide through our Joint Venture.''

``We are very excited that we can offer an alternative treatment for the millions of people that are afflicted with this type of skin disorder,'' stated Timothy J. Shea, Executive Vice President and COO of the Company. ``We have recently shipped an EX-308 to Duke University Medical Center to continue our research on other related skin disorders. Claude Burton, M.D., Associate Professor of Dermatology and Director of the Laser Clinic at Duke will begin using the EX-308 on psoriasis as well as investigating new uses for this technology. Having someone as experienced with the use of lasers like Dr. Burton and a facility like Duke working with us to expand our capabilities is exciting and we look forward to expanding our capabilities and further enhance our technology.''

The Company's EX-308 excimer laser has only one competitor. Photomedex, formerly Laser Photonics, (Nasdaq:PHMD - news) received FDA clearance for psoriasis earlier this year. SurgiLight is also conducting clinical trials outside the U.S. with its second system, the IR-3000 and believes that this laser is the first infrared (IR) laser system designed for the treatment of presbyopia. The IR-3000 is fundamentally different from the thermal IR laser made by Sunrise (Nasdaq:SNRS - news) and the UV lasers made by VISX (Nasdaq:VISX - news), LaserSight (Nasdaq:LASE - news), Summit (Nasdaq:BEAM - news), Bausch and Lomb (NYSE:BOL - news) and Nidek (Japan).



To: Jon Matz who wrote (829)8/17/2000 9:57:27 AM
From: Eric Fader  Read Replies (1) | Respond to of 3785
 
( BW)(CA-STAYHEALTHY-INC) Stayhealthy Announces
Partnership With PharMerica; Leading Web-Enabled
Products and Services Company to Use Innovative Tools in
Partnership With Assisted Living Market Leader

Business Editors & Health/Medical Writers

MONROVIA, Calif.--(BUSINESS WIRE)--Aug. 17, 2000--Stayhealthy, Inc., a
leading online company dedicated to empowering consumers to monitor their
health and fitness, has signed a partnership agreement with PharMerica, the leading
provider of professional quality pharmacy products and services to the long-term
care, assisted living, sub acute, and skilled nursing industries. John Collins, chief
executive officer of Stayhealthy, and Charles J. Carpenter, PharMerica's president
and chief executive officer, made the announcement today.

Under the terms of the agreement, Stayhealthy will integrate its innovative,
Web-enabled products and services into PharMerica's diverse product offerings
through its nationwide network of 145 pharmacies. PharMerica serves more than
330,000 residents living in skilled nursing and assisted living facilities, residential
and independent living communities, specialty hospitals and home settings.
PharMerica's services also include home pharmacy support that delivers
medicines, medical supplies and equipment to the workers' compensation
claimant, home bound chronically ill and catastrophically injured populations.

The companies plan to launch the partnership with a pilot program in which
Stayhealthy devices will be installed and used in nursing home facilities that
PharMerica services. Stayhealthy's state-of-the-art equipment will be used to test
and monitor residents, each of whom will be provided with a private, password
protected Web page where the resident's readings can be stored, displayed and
accessed by the residents, their families and caregivers.

Stayhealthy will also establish private e-mail accounts to facilitate patient
communications with their family and caregivers. In addition, Stayhealthy will
create a shopping cart solution for use by PharMerica and its customers to order
health care and nutritional products and supplies.

"The partnership with Stayhealthy is significant to PharMerica's Web-enabled
business initiatives because it offers an innovative approach to enhance and
broaden our service offerings to our long-term care customers," said Carpenter.
"The development of Web-based offerings helps us continue to achieve our goal
of extending quality patient care and aggressively maximizing efficiencies via
Internet applications."

Through call center support, Web-connectivity and instant e-mail, Stayhealthy's
direct-to-consumer and business-to-business marketing programs, products and
services will provide improved functionality and substantial content to
PharMerica.

"Working with an industry leader like PharMerica allows us to introduce our
products and services to the large, rapidly growing assisted care market and gives
PharMerica easy-to-use, highly accurate tools that enhance the value and
effectiveness of PharMerica's service to its customers," said Collins.

Stayhealthy's products include the BC1 Body Composition and Calorie
Tracker, a simple desktop device that allows users to accurately monitor their
body composition and measure caloric burn. An essential tool for any weight
management or fitness program, the BC1 works with Stayhealthy software to
connect users to the Stayhealthy Web site at www.stayhealthy.com through their
existing Internet connection and view performance graphs, news and other
personalized information in a secure, password-protected environment.

Stayhealthy is leading the development of Web-enabled products and services
for management and measurement of weight, blood pressure and heart rate,
hearing loss, vision and colorblindness and respiratory function. Created for
consumer and clinical use, the company's leading-edge products and services
facilitate better communication and increase efficiencies between doctors and
patients and health-care facilities, reduce the need for in-person appointments and
improve opportunities for early illness detection. In doing so, Stayhealthy's
comprehensive home monitoring programs create mutually beneficial opportunities
for a wide variety of industries and professionals such as self-insured employers,
physicians, dieticians, nutritionists, fitness trainers, health club owners, insurers
and others.

Headquartered in Tampa, Fla., PharMerica operates more than 145 pharmacies
nationwide and is a leading provider of pharmacy products and services to
approximately 330,000 residents living in skilled nursing facilities; assisted-living
facilities; residential and independent-living communities; specialty hospitals; and
the home setting. The company is a wholly owned subsidiary of Bergen Brunswig
Corporation (BBC), a leading supplier of pharmaceuticals, medical-surgical
supplies, specialty health-care products, information management solutions and
consulting services for the nation's leading health-care providers, drug stores,
manufacturers and patients. Through product distribution, pharmacy management
programs and Internet fulfillment strategies, the company is dedicated to reducing
costs and improving patient outcomes across the health-care spectrum. For more
information, contact PharMerica at 813/626-7788 or visit the PharMerica Web site
at www.pharmerica.com.

Headquartered in Monrovia, Stayhealthy is a leader in developing and marketing
Web-enabled products and services that empower consumers to screen, assess
and monitor their health. The company's proprietary programs are accessed
through its comprehensive health Web site that features a comprehensive drug
database, original health, nutrition and fitness content, and e-commerce. For more
information, contact Stayhealthy at 626/256-6152 or visit the Stayhealthy Web site
at www.stayhealthy.com.

--30--JC/la*

CONTACT: Stayhealthy.com
Peter Bylsma, 626/256-6152
or
PharMerica, Tampa
Michael McCarthy, 813/626-7788

KEYWORD: CALIFORNIA FLORIDA
INDUSTRY KEYWORD: INTERNET MEDICAL MARKETING AGREEMENTS



To: Jon Matz who wrote (829)8/17/2000 10:14:02 AM
From: Eric Fader  Read Replies (2) | Respond to of 3785
 
<Hello Eric, what in your opinion is the center of this venture, is it not the website and the products they will sell from it?>

Hi Jon, nice to see you. Nope - you seem to have grasped the 1% and missed the other 99%. Stayhealthy is a Web-enabled medical device company, not merely an e-commerce company selling supplements and similar products. Stay's technology, which to my knowledge no other company has and for which Stay has applied for a patent, allows the sensor or detector in a clinical-grade medical device to be separated from the algorithms that convert the raw sensor data into usable and displayable form. That enables Stay to sell the (much simpler) devices at a fraction of the cost of the traditional version, while the conversion of the raw data into usable form occurs at the other end of the Internet - on Stay's own servers. People log on to the Web site to upload data and track their results, and while they're there they might buy some products (and we haven't seen their rumored 10,000+ product fulfillment deal reflected on the site yet), but that's a very minor part of the business plan.

Maybe you should read this carefully:

Stayhealthy is leading the development of Web-enabled products and services
for management and measurement of weight, blood pressure and heart rate,
hearing loss, vision and colorblindness and respiratory function. Created for
consumer and clinical use, the company's leading-edge products and services
facilitate better communication and increase efficiencies between doctors and
patients and health-care facilities, reduce the need for in-person appointments and
improve opportunities for early illness detection. In doing so, Stayhealthy's
comprehensive home monitoring programs create mutually beneficial opportunities
for a wide variety of industries and professionals such as self-insured employers,
physicians, dieticians, nutritionists, fitness trainers, health club owners, insurers
and others.